| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 122 |
| 1 | ADALIMUMAB | 105 |
| 2 | METHOTREXATE SODIUM | 98 |
| 3 | PREDNISOLONE | 94 |
| 4 | PREDNISOLONE ORAL | 94 |
| 5 | PREDNISOLONE ORAL SOLUTION | 94 |
| 6 | METHOTREXATE | 90 |
| 7 | RITUXIMAB | 76 |
| 8 | ACETAMINOPHEN | 73 |
| 9 | TACROLIMUS | 68 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROVALIMAB | 3 | 0.0248 |
| 1 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 1 | 0.0169 |
| 2 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 3 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 4 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 5 | HISTAMINE | 1 | 0.0069 |
| 6 | GLASDEGIB | 3 | 0.0063 |
| 7 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 8 | CROTAMITON | 2 | 0.0033 |
| 9 | BUTORPHANOL TARTRATE | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 326 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 149 |
| 2 | Proton Pump Inhibitor [EPC] | 112 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 96 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 91 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 90 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 73 |
| 7 | Benzodiazepine [EPC] | 70 |
| 8 | Alkylating Drug [EPC] | 68 |
| 9 | Loop Diuretic [EPC] | 67 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 3 | 0.0248 |
| 1 | Lead Chelator [EPC] | 1 | 0.0119 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 5 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 6 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 7 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 8 | Neurokinin 3 Receptor Antagonist [EPC] | 2 | 0.0009 |
| 9 | Chloride Channel Activator [EPC] | 8 | 0.0008 |